Literature DB >> 21475235

A Src link in schizophrenia.

Chang-Gyu Hahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21475235     DOI： 10.1038/nm0411-425

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

Review 1.  Src kinases: a hub for NMDA receptor regulation.

Authors:  Michael W Salter; Lorraine V Kalia
Journal:  Nat Rev Neurosci       Date:  2004-04       Impact factor: 34.870

2.  Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain.

Authors:  E S Anton; H T Ghashghaei; Janet L Weber; Corey McCann; Tobias M Fischer; Isla D Cheung; Martin Gassmann; Albee Messing; Rudiger Klein; Markus H Schwab; K C Kent Lloyd; Cary Lai
Journal:  Nat Neurosci       Date:  2004-11-07       Impact factor: 24.884

Review 3.  N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

Authors:  Joshua T Kantrowitz; Daniel C Javitt
Journal:  Brain Res Bull       Date:  2010-04-24       Impact factor: 4.077

4.  Neurobiology: new order for thought disorders.

Authors:  Lorna W Role; David A Talmage
Journal:  Nature       Date:  2007-07-19       Impact factor: 49.962

5.  Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

Authors:  Graham M Pitcher; Lorraine V Kalia; David Ng; Nathalie M Goodfellow; Kathleen T Yee; Evelyn K Lambe; Michael W Salter
Journal:  Nat Med       Date:  2011-03-27       Impact factor: 53.440

6.  Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease.

Authors:  Amanda J Law; Barbara K Lipska; Cynthia Shannon Weickert; Thomas M Hyde; Richard E Straub; Ryota Hashimoto; Paul J Harrison; Joel E Kleinman; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

7.  Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

Authors:  Lei Wen; Yi-Sheng Lu; Xin-Hong Zhu; Xiao-Ming Li; Ran-Sook Woo; Yong-Jun Chen; Dong-Min Yin; Cary Lai; Alvin V Terry; Almira Vazdarjanova; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

Review 8.  Neuregulin 1 and schizophrenia.

Authors:  Hreinn Stefansson; Valgerdur Steinthorsdottir; Thorgeir E Thorgeirsson; Jeffrey R Gulcher; Kari Stefansson
Journal:  Ann Med       Date:  2004       Impact factor: 4.709

Review 9.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

10.  Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients.

Authors:  Victor Z Chong; Mia Thompson; Senda Beltaifa; Maree J Webster; Amanda J Law; Cynthia Shannon Weickert
Journal:  Schizophr Res       Date:  2008-02-19       Impact factor: 4.939
View more
  7 in total

Review 1.  Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Authors:  Xiangyou Hu; Qingyuan Fan; Hailong Hou; Riqiang Yan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

2.  Global signaling effects of a schizophrenia-associated missense mutation in neuregulin 1: an exploratory study using whole genome and novel kinome approaches.

Authors:  Ketan K Marballi; Robert E McCullumsmith; Stefani Yates; Michael A Escamilla; Robin J Leach; Henriette Raventos; Consuelo Walss-Bass
Journal:  J Neural Transm (Vienna)       Date:  2014-01-01       Impact factor: 3.575

3.  Nicotine-induced neuroplasticity counteracts the effect of schizophrenia-linked neuregulin 1 signaling on NMDAR function in the rat hippocampus.

Authors:  Yoshihiko Yamazaki; Katumi Sumikawa
Journal:  Neuropharmacology       Date:  2016-10-23       Impact factor: 5.250

Review 4.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

5.  Revisiting Schizophrenia from an Evolutionary Perspective: An Association Study of Recent Evolutionary Markers and Schizophrenia.

Authors:  Upasana Bhattacharyya; Smita N Deshpande; Triptish Bhatia; B K Thelma
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

6.  The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia.

Authors:  Karin E Borgmann-Winter; Kai Wang; Sabyasachi Bandyopadhyay; Abolfazl Doostparast Torshizi; Ian A Blair; Chang-Gyu Hahn
Journal:  Schizophr Res       Date:  2019-08-13       Impact factor: 4.662

7.  Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK.

Authors:  Dimitrios Kotzadimitriou; Wiebke Nissen; Melinda Paizs; Kathryn Newton; Paul J Harrison; Ole Paulsen; Karri Lamsa
Journal:  eNeuro       Date:  2018-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.